Enliven Therapeutics ELVN
Last Price
52 Week Range
$13.30 - $30.22
Next Earnings Date
Mar 12 2026 (Estimate)
Next Earnings Date
Mar 12 2026 (Est.)
Last Price
ELVN Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Enliven Therapeutics, Inc. | 8-K | January 7, 2026 | |
Enliven Therapeutics, Inc. | 8-K | December 11, 2025 | |
Enliven Therapeutics, Inc. | 10-Q | November 12, 2025 | |
Enliven Therapeutics, Inc. | 8-K | November 12, 2025 | |
Enliven Therapeutics, Inc. | 8-K | August 13, 2025 | |
Enliven Therapeutics, Inc. | 10-Q | August 13, 2025 | |
Enliven Therapeutics, Inc. | S3ASR | August 13, 2025 | |
Enliven Therapeutics, Inc. | 8-K | June 25, 2025 | |
Enliven Therapeutics, Inc. | 8-K | June 16, 2025 | |
Enliven Therapeutics, Inc. | 8-K | June 13, 2025 | |
Enliven Therapeutics, Inc. | 10-Q | May 14, 2025 | |
Enliven Therapeutics, Inc. | 8-K | May 14, 2025 | |
Enliven Therapeutics, Inc. | DEF 14A | April 28, 2025 | |
Enliven Therapeutics, Inc. | ARS | April 28, 2025 | |
Enliven Therapeutics, Inc. | DEFA14A | April 28, 2025 | |
Enliven Therapeutics, Inc. | 10-K | March 13, 2025 | |
Enliven Therapeutics, Inc. | 8-K | March 13, 2025 | |
Enliven Therapeutics, Inc. | 10-Q | November 13, 2024 | |
Enliven Therapeutics, Inc. | 8-K | November 13, 2024 | |
Enliven Therapeutics, Inc. | 8-K | August 13, 2024 | |
Enliven Therapeutics, Inc. | 10-Q | August 13, 2024 | |
Enliven Therapeutics, Inc. | 8-K | June 18, 2024 | |
Enliven Therapeutics, Inc. | 10-Q | May 14, 2024 | |
Enliven Therapeutics, Inc. | 8-K | May 14, 2024 | |
Enliven Therapeutics, Inc. | DEF 14A | April 26, 2024 | |
Enliven Therapeutics, Inc. | ARS | April 26, 2024 | |
Enliven Therapeutics, Inc. | DEFA14A | April 26, 2024 | |
Enliven Therapeutics, Inc. | PRE 14A | April 15, 2024 | |
Enliven Therapeutics, Inc. | 8-K | April 11, 2024 | |
Enliven Therapeutics, Inc. | 8-K | April 9, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.